How to use ixazomib capsules? Latest medication encyclopedia

Ixazomib capsule is an oral proteasome inhibitor that blocks the growth and spread of tumor cells by inhibiting the activity of the proteasome, thereby achieving the purpose of treating multiple myeloma. The drug, often used in combination with lenalidomide and dexamethasone, can significantly improve patients' progression-free survival. As an important anti-tumor drug, ixazomib has been widely used worldwide. This article will give you a detailed introduction to the use of ixazomib capsules and the latest medication guidelines to help you better understand and use this drug.

1. How to use

1. Dosage and usage

The recommended starting dose of ixazomib capsules is4 mg, administered orally once a week on days 1, 8 and 15 of a 28-day treatment cycle. The recommended starting dose of lenalidomide is 25 mg once daily for 21 consecutive days. The recommended starting dose of dexamethasone is 40 mg on days 1, 8, 15, and 22 of a 28-day treatment cycle.

2. Medication time and method

Patients should take the drug at approximately the same time on days 1, 8 and 15 of each treatment cycle to ensure a stable concentration of the drug in the body. Ixazomib capsules should be taken at least 1 hour before or 2 hours after a meal to reduce the impact of food on drug absorption. Also, take the entire capsule with water and do not crush, chew, or open the capsule.

3. Missed dose and make-up dose

If the patient delays or misses a dose of ixazomib capsules, the missed dose can only be taken when the next scheduled dose time is ≥72 hours. A missed dose must not be taken within 72 hours of the next scheduled dose, and a double dose must not be taken to make up for a missed dose. If the patient vomits after taking the medication, the medication should not be repeated but should be resumed at the next scheduled dose.

2. Precautions

1. Regular inspection

During treatment with ixazomib capsules, patients should regularly check blood routine and liver and kidney function to monitor possible side effects caused by the drug.

2. Drug interactions

Ixazomib capsules may interact with certain drugs, such asstrong CYP3A inducers. Therefore, when using ixazomib capsules, doctors should be informed of all medications being used to avoid adverse interactions.

3. Medication for special groups of people

Patients with renal impairment may require dose adjustment or renal function monitoring while taking ixazomib capsules. In addition, pregnant and breastfeeding women should consult their doctor before using this drug.

3. Storage conditions

Store ixazomib capsules at room temperature. Do not store at temperatures above30°C (86°F). Do not freeze. Keep capsules in original packaging until use.

4. Price and purchasing channels

According to available information, ixazomib has been launched in China and has been included in medical insurance. However, due to regional differences, specific drug pricing and medical insurance policies will vary. Therefore, it is recommended that patients consult local medical institutions or medical insurance departments for detailed consultation based on their region to understand the exact cost and reimbursement policies. In addition, it is worth noting that there is a generic version of the drug produced by Lucius Pharmaceuticals on the Laos market. Its price is relatively affordable, with each box (containing 4mg*3 tablets) priced at about 900 yuan. Patients can consider whether to purchase this generic version from Laos based on their own circumstances.

In conclusion, ixazomib capsule, as an important anti-tumor drug, has significant efficacy in the treatment of multiple myeloma. However, during use, patients should strictly follow the doctor's medication instructions and pay attention to the dosage, usage, medication time and precautions of the drug. Through correct medication methods and compliance with precautions, patients can better utilize ixazomib capsules for treatment and improve treatment effects and quality of life.